Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-17 Sale |
2024-10-18 6:25 pm |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
21,788 | $17.03 | $370,962 | 205,321 (Direct) |
View |
| 2024-03-20 Sale |
2024-03-22 4:31 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
60,000 | $44.14 | $2,648,150 | 18,536 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 12:54 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
12,195 | $50.88 | $620,443 | 14,860 (Direct) |
View |
| 2023-06-07 Sale |
2023-06-09 2:32 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
3,300 | $51.82 | $171,006 | 34,165 (Direct) |
View |
| 2022-07-13 Sale |
2022-07-15 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,700 | $20.96 | $119,455 | 12,536 (Direct) |
View |
| 2021-11-04 Sale |
2021-11-05 4:28 pm |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
13,354 | $19.5 | $260,403 | 31,500 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:55 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
8,954 | $25.5 | $228,327 | 24,628 (Direct) |
View |
| 2021-09-08 Sale |
2021-09-09 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
6,046 | $25.5 | $154,173 | 33,582 (Direct) |
View |
| 2021-07-26 Sale |
2021-07-27 8:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $19.59 | $97,950 | 39,628 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $19.5 | $97,500 | 44,628 (Direct) |
View |
| 2021-07-12 Sale |
2021-07-13 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $20.71 | $103,550 | 49,628 (Direct) |
View |
| 2020-07-06 Sale |
2020-07-08 12:30 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $90 | $556,290 | 13,550 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 2:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $85 | $425,000 | 19,731 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-19 7:13 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
1,875 | $75 | $140,625 | 11,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2031-04-23 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
141,959 | $0 | 141,959 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A 2030-09-07 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
21,788 | $0 | 205,321 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
3,783 | $8.32 | 205,321 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
8,005 | $8.79 | 205,321 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
10,000 | $2.52 | 205,321 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 2:26 pm |
N/A 2034-06-18 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
15,245 | $0 | 30,105 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:13 pm |
N/A 2034-06-12 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
48,671 | $0 | 48,671 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:19 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
15,900 | $0 | 34,436 (Direct) |
View |
| 2024-03-31 Option Award |
2024-04-02 6:13 pm |
N/A N/A |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
150,000 | $0 | 259,000 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:31 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
12,500 | $23.24 | 18,536 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:31 pm |
N/A 2029-06-20 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
60,000 | $0 | 18,536 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:31 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
17,500 | $18.29 | 18,536 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:31 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
17,500 | $20.23 | 18,536 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:31 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
12,500 | $23.23 | 18,536 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:51 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
27,802 | $0 | 27,802 (Direct) |
View |
Ownership |
2023-09-14 6:57 pm |
N/A 2030-09-07 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
0 | $0 | 107,374 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
23,500 | $0 | 36,036 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:32 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
10,970 | $0 | 34,165 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:09 pm |
N/A 2033-05-30 |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
136,500 | $0 | 188,500 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 4:30 pm |
N/A 2027-11-05 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,700 | $0 | 12,536 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,700 | $1.45 | 12,536 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:52 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
9,545 | $0 | 32,740 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:48 pm |
N/A 2032-06-22 |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
52,000 | $0 | 83,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:46 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 12:25 pm |
N/A 2024-07-10 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
7,500 | $0 | 23,195 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 12:25 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
7,500 | $40.37 | 23,195 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:55 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
8,954 | $0 | 24,628 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:55 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
8,954 | $1.91 | 24,628 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 5:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
6,046 | $0 | 33,582 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 5:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
6,046 | $1.91 | 33,582 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-27 8:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $0 | 39,628 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-27 8:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $1.91 | 39,628 (Direct) |
View |
| 2021-07-19 Exercise |
2021-07-20 5:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $0 | 44,628 (Direct) |
View |
| 2021-07-19 Exercise |
2021-07-20 5:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $1.91 | 44,628 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 5:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $0 | 49,628 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 5:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $1.91 | 49,628 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:24 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,270 | $0 | 19,820 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-09 7:05 pm |
N/A 2031-06-07 |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
28,500 | $0 | 62,354 (Direct) |
View |
| 2020-07-06 Exercise |
2020-07-08 12:30 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $0 | 13,550 (Direct) |
View |
| 2020-07-06 Exercise |
2020-07-08 12:30 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $21 | 13,550 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $0 | 19,731 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $21 | 19,731 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:12 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,800 | $0 | 17,800 (Direct) |
View |
| 2020-06-19 Option Award |
2020-06-22 4:24 pm |
N/A 2030-06-18 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-17 5:45 pm |
N/A 2030-06-15 |
Atara Biotherapeutics Inc. | ATRA | Fust Matthew K Director |
32,500 | $0 | 58,354 (Direct) |
View |